Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diagnostic Agent Adverse Reaction”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00365781
What this trial is testing

Examination of Dermatologic Effects From Subcutaneous Injections of ISIS 113715

Who this might be right for
Type 2 Diabetes Mellitus
Ionis Pharmaceuticals, Inc. 10
Not applicableStudy completedNCT03468309
What this trial is testing

Medication Optimization Using Pharmacogenetic Testing and the G-DIG to Reduce Polypharmacy in a Mental Health Population

Who this might be right for
Pharmacogenetic Testing
Seattle Institute for Biomedical and Clinical Research 53
Not applicableNot Yet RecruitingNCT07715994
What this trial is testing

A Computer-Assisted Tool for Objective Assessment of Extrapyramidal Symptoms

Who this might be right for
Extrapyramidal SymptomsDrug-induced ParkinsonismAkathisia, Drug-Induced+1 more
Shanghai Mental Health Center 180
Not applicableEnded earlyNCT01320072
What this trial is testing

Diagnosis of Aspirin Hypersensitivity in Aspirin Exacerbated Respiratory Disease

Who this might be right for
Asthma, Aspirin-induced
Montefiore Medical Center 29
Not applicableStudy completedNCT02162173
What this trial is testing

Dual Focus NBI and pCLE in FAP Related Duodenal Adenoma

Who this might be right for
Complication of Diagnostic ProcedureAdverse Effect of Diagnostic Agents, Subsequent Encounter
King Chulalongkorn Memorial Hospital 26
Not applicableStudy completedNCT03347370
What this trial is testing

A Post-Authorization Safety Study of Interferon Beta Therapy in Participants With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Biogen 626
Very early researchStudy completedNCT03420469
What this trial is testing

Bupropion Stereoselective Disposition and CYP2D6-mediated Drug Interactions in Healthy Volunteers

Who this might be right for
Adverse Effect of Drug Therapy Metabolism Medications (Diagnosis)
Indiana University 28
Not applicableNot Yet RecruitingNCT07011212
What this trial is testing

In Search of the Correct Diagnosis of Beta-lactam Allergy: From the Validation of a Risk Stratification Tool to Accurate Endotyping

Who this might be right for
Drug Allergy
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud 332
Not applicableStudy completedNCT03787966
What this trial is testing

Attenuating Cancer Treatment-related Toxicity in Oncology Patients With a Tailored Physical Exercise Program

Who this might be right for
Breast Neoplasms
Universidad de Granada 100
Not applicableEnded earlyNCT00213642
What this trial is testing

Tc-99m Renography and Cisplatin-induced Nephrotoxicity

Who this might be right for
CancerDrug ToxicityKidney Failure
University Hospital, Rouen 20
Not applicableStudy completedNCT03743220
What this trial is testing

Drug Provocation Test (DPT) to Non Steroidal Anti-inflammatory Drugs (NSAID)

Who this might be right for
Drug Hypersensitivity
University Hospital, Montpellier 311
Post-approval studies (Phase 4)Study completedNCT03183908
What this trial is testing

FLUAD® vs. Fluzone® High-Dose Study

Who this might be right for
PainQuality of LifeInjection Site Reaction+2 more
Duke University 757
Post-approval studies (Phase 4)Study completedNCT00199745
What this trial is testing

Differences in Atorvastatin Metabolite Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity

Who this might be right for
Muscular Diseases
Oslo University Hospital 53
Post-approval studies (Phase 4)UnknownNCT03424733
What this trial is testing

Evaluating the Use of Prednisone to Decrease Pegylated Interferon Beta-1a Side Effects

Who this might be right for
Multiple Sclerosis
Holy Name Medical Center, Inc. 50
Not applicableStudy completedNCT05676606
What this trial is testing

Cardiotoxicity Monitoring With Single-lead Electrocardiogram

Who this might be right for
Cardiotoxicity
I.M. Sechenov First Moscow State Medical University 120
Not applicableUnknownNCT05411250
What this trial is testing

Early Diagnosis of Therapy-associated Cardiotoxicity Basing on PET/CT in Lymphoma

Who this might be right for
Positron-Emission Tomography
Peking University Cancer Hospital & Institute 40
Not applicableStudy completedNCT05157191
What this trial is testing

Safety of Pediatric COVID-19 Vaccination

Who this might be right for
PainInjection Site ReactionAdverse Drug Event
Duke University 299
Testing effectiveness (Phase 2)Looking for participantsNCT06406114
What this trial is testing

Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing

Who this might be right for
Drug AllergyCephalosporin AllergyDrug Hypersensitivity+4 more
Massachusetts General Hospital 300
Not applicableStudy completedNCT03581604
What this trial is testing

De-labeling of Patients With False Diagnosis of Penicillin Allergy

Who this might be right for
Allergy Drug
Oslo University Hospital 155
Post-approval studies (Phase 4)WithdrawnNCT02568111
What this trial is testing

Brimonidine Tartrate for the Treatment of Injection Related Erythema

Who this might be right for
Relapsing-Remitting Multiple Sclerosis (RRMS)
Biogen
Next Page